{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

HKTDC to Host World's Largest One-stop Jewellery Marketplace

February 5, 2026New Hard Pure Gold Pavilion Showcases Breakthrough Gold Technologies HONG KONG - February 5, 2026 (NEWMEDIAWIRE) - Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one-stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld-Expo and will feature a wide range of jewellery raw materials.


Helix Biopharma Corp. Extends LEUMUNA Option With metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

February 5, 2026TORONTO, ONTARIO - February 5, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company shaping a near future where today’s hard-to-treat cancers are vincible, today announced the extension of its Research and Exclusive Option Agreement (the “Agreement”) with metaShape Pharma AG (“metaShape”) covering LEUMUNA™ through December 31, 2028.


Datavault AI (DVLT) Issues Stockholder Letter Highlighting 2025 Milestones, 2026 Expansion Outlook

February 5, 2026LOS ANGELES, CA - February 5, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced the release of a letter from Chief Executive Officer Nathaniel Bradley to stockholders outlining the company’s accomplishments in 2025 and its strategic priorities for 2026, including expanded national infrastructure rollouts, commercialization of data monetization and tokenization platforms, and scaling secure edge-node deployments across more than 100 U. S.


New Medication May Reduce Chances of a Second Clot-Caused Stroke Without Bleeding Risk

February 5, 2026Research Highlights: When added to standard blood-thinning medications such as aspirin, the new anti-clotting medication asundexian reduced the risk of a second stroke by reducing the formation of blood clots without increasing the risk of bleeding. This is the first completed trial of a Factor XI inhibitor investigating whether the medication asundexian is better than standard therapy at safely preventing recurrent strokes.


Focus Universal Announces Reverse Stock Split

February 5, 2026ONTARIO, CA - February 5, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (Nasdaq: FCUV) (“Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G, announces that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock (the “Reverse Split”).


Lexaria Announces Positive Final Results From Human Pilot Study #5

February 5, 2026Company Further Examining the Pursuit of the World’s First Oral Liraglutide Product KELOWNA, BRITISH COLUMBIA - February 5, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce final results from Human Pilot Study #5 (GLP-1-H25-5) (the “Study”) which compared oral DehydraTECH-liraglutide (“DHT-LIR”) capsules to injected Saxenda® branded liraglutide (“SAX-LIR”).


136 Schools Nationwide Awarded Grants to Improve Student, Faculty Health

February 4, 2026DALLAS - February 4, 2026 (NEWMEDIAWIRE) - Physical activity is vital to American students’ physical health and emotional well-being, helping them learn, concentrate and manage stress throughout the school day, yet most youth are not getting enough movement. According to the American Heart Association, only 1 in 4 children ages 6 to 11 are currently getting the recommended 60 minutes of daily physical activity - a statistic that more than doubles for youth ages 12 to 17.


PVA TePla Significantly Increases Order Intake in 2025 - Moderate Revenue and Earnings Growth Expected for 2026

February 4, 2026WETTENBERG, GERMANY - February 4, 2026 (NEWMEDIAWIRE) - In a market environment that remains challenging, PVA TePla AG closed the fiscal year 2025 with a significant increase in order intake, thus creating a solid foundation for further business development. Operating performance was significantly impacted by delays in the realization and acceptance of individual projects, which had an effect on revenue and earnings.


Elmos Semiconductor SE is Planning to Distribute 36 Million Euro to Shareholders for the Fiscal Year 2025

February 4, 2026Management Board and Supervisory Board Approve Share Buyback Program of 10 million Euro and Dividend Increase of 50% to 1. 50 Euro Per Share LEVERKUSEN, GERMANY - February 4, 2026 (NEWMEDIAWIRE) - The Management Board of Elmos Semiconductor SE (FSE: ELG) has decided, with the approval of the Supervisory Board, to further develop its dividend policy, thereby sending a clear signal for attractive and sustainable capital allocation.


NeuroOne® to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time

February 4, 2026EDEN PRAIRIE, MINN. - February 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2025, before market open on February 17, 2026.